Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Change in Account Payables: 2010-2025

Historic Change in Account Payables for Prestige Consumer Healthcare (PBH) over the last 16 years, with Sep 2025 value amounting to $19.8 million.

  • Prestige Consumer Healthcare's Change in Account Payables rose 341.71% to $19.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.7 million, marking a year-over-year increase of 178.05%. This contributed to the annual value of -$19.4 million for FY2025, which is 22.27% up from last year.
  • Latest data reveals that Prestige Consumer Healthcare reported Change in Account Payables of $19.8 million as of Q3 2025, which was up 618.03% from $2.8 million recorded in Q2 2025.
  • Prestige Consumer Healthcare's 5-year Change in Account Payables high stood at $19.8 million for Q3 2025, and its period low was -$15.6 million during Q2 2021.
  • Its 3-year average for Change in Account Payables is -$2.1 million, with a median of -$1.6 million in 2023.
  • In the last 5 years, Prestige Consumer Healthcare's Change in Account Payables slumped by 766.38% in 2023 and then soared by 366.33% in 2025.
  • Prestige Consumer Healthcare's Change in Account Payables (Quarterly) stood at $2.2 million in 2021, then spiked by 258.65% to $7.9 million in 2022, then tumbled by 165.31% to -$5.1 million in 2023, then tumbled by 118.80% to -$11.3 million in 2024, then surged by 341.71% to $19.8 million in 2025.
  • Its Change in Account Payables was $19.8 million in Q3 2025, compared to $2.8 million in Q2 2025 and -$560,000 in Q1 2025.